He later clarified, “Technically, Mounjaro, but that doesn’t have the same ring to it.” Banks’ comments were reportedly triggered by Grimes’ reaction to a meme on X that lamented the ...

Elon Musk's Christmas post has taken social media by storm! Dressed as a slimmer Santa, Musk's weight-loss transformation has everyone talking. Captioned as "Ozempic Santa," the Tesla CEO later ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

"Technically, Mounjaro, but that doesn't have the same ... with the SpaceX founder — reacting to a meme on X portraying the "212" rapper and the "Genesis" singer as Glinda and Elphaba from ...

The rapper was reportedly not happy with a meme shared on the micro-blogging site that presented Banks as Elphaba from the movie ‘Wicked’ and Grimes as Glinda. Musk’s former partner, who shares son X ...

Mounjaro vs. Ozempic: Which Is Better for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re ...

The natural Mounjaro drink has no scientific backing for weight loss effects comparable to FDA-approved tirzepatide While safe to consume, it lacks essential nutrients and shouldn't replace ...

Musk elaborated in a follow-up post he is technically using the Eli Lilly weight-loss drug Mounjaro over Novo Nordisk’s Ozempic, “but that doesn’t have the same ring to it.” The post comes ...

A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar weight-loss drugs as a means to curb America’s obesity epidemic. The ...

Mounjaro is a GLP-1 inhibitor developed to help people with diabetes regulate their blood glucose. Elon Musk, the 53-year-old CEO of Tesla and SpaceX, recently shared a festive image of himself ...

From heart and kidney health to addiction reduction, GLP-1 drugs like Ozempic and Mounjaro may help with more than just weight loss Steve Christo/Corbis/Corbis/Getty ...

Eli Lilly, a leading US pharmaceutical company, is gearing up to launch its groundbreaking diabetes and obesity medication, Tirzepatide—commercially known as Mounjaro—in India by 2025.